InvestorsHub Logo
Followers 1
Posts 375
Boards Moderated 0
Alias Born 12/02/2013

Re: None

Wednesday, 10/08/2014 8:42:16 PM

Wednesday, October 08, 2014 8:42:16 PM

Post# of 9558
Looking over the last two press releases, a couple of things stand out:
1. The FDA approval process is beginning.
2. It was MD Anderson that called MRX "Unparalleled" in sensitivity and holds promise for much earlier detection of ovarian cancer.
3."Results released by MD Anderson Cancer Center"
IMO, This adds up to miles and miles of progress!